These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39351366)

  • 1. Association of
    Liu Z; Zhou Y; Jin M; Liu S; Liu S; Yang K; Li H; Luo S; Jureti S; Wei M; Fu Z
    PeerJ; 2024; 12():e18144. PubMed ID: 39351366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of age and gender on the relationship between HMGCR promoter-911 SNP (rs33761740) and serum lipids in patients with coronary heart disease.
    Akadam-Teker B; Kurnaz O; Coskunpinar E; Daglar-Aday A; Kucukhuseyin O; Cakmak HA; Teker E; Bugra Z; Ozturk O; Yilmaz-Aydogan H
    Gene; 2013 Oct; 528(2):93-8. PubMed ID: 23933271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGCR rs17671591 SNP Determines Lower Plasma LDL-C after Atorvastatin Therapy in Chilean Individuals.
    Cuevas A; Fernández C; Ferrada L; Zambrano T; Rosales A; Saavedra N; Salazar LA
    Basic Clin Pharmacol Toxicol; 2016 Apr; 118(4):292-7. PubMed ID: 26408409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the GALNT2 gene polymorphisms and several environmental factors with serum lipid levels in the Mulao and Han populations.
    Li Q; Yin RX; Yan TT; Miao L; Cao XL; Hu XJ; Aung LH; Wu DF; Wu JZ; Lin WX
    Lipids Health Dis; 2011 Sep; 10():160. PubMed ID: 21933382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic association of lipid-lowering drugs with aortic aneurysms: a Mendelian randomization study.
    Gao X; Luo W; Qu L; Yang M; Chen S; Lei L; Yan S; Liang H; Zhang X; Xiao M; Liao Y; Lee AP; Zhou Z; Chen J; Zhang Q; Wang Y; Xiu J
    Eur J Prev Cardiol; 2024 Jul; 31(9):1132-1140. PubMed ID: 38302118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy.
    Poduri A; Khullar M; Bahl A; Sehrawat BS; Sharma Y; Talwar KK
    DNA Cell Biol; 2010 Oct; 29(10):629-37. PubMed ID: 20578904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between CYP3A5*3 and POR*28 polymorphisms and lipid lowering response with atorvastatin.
    Wei KK; Zhang LR
    Clin Drug Investig; 2015 Sep; 35(9):583-91. PubMed ID: 26293521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.
    Ference BA; Kastelein JJP; Ginsberg HN; Chapman MJ; Nicholls SJ; Ray KK; Packard CJ; Laufs U; Brook RD; Oliver-Williams C; Butterworth AS; Danesh J; Smith GD; Catapano AL; Sabatine MS
    JAMA; 2017 Sep; 318(10):947-956. PubMed ID: 28846118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mendelian randomization study of lipid metabolism characteristics and migraine risk.
    Hong P; Han L; Wan Y
    Eur J Pain; 2024 Jul; 28(6):978-986. PubMed ID: 38183343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of methylenetetrahydrofolate reductase C677T polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations.
    Zhang L; Yin RX; Liu WY; Miao L; Wu DF; Aung LH; Hu XJ; Cao XL; Wu JZ; Pan SL
    Lipids Health Dis; 2010 Oct; 9():123. PubMed ID: 20977771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial comparing the efficacy of daily and every other day atorvastatin therapy and its correlation with serum hydroxymethylglutaryl-CoA reductase enzyme levels in naïve dyslipidemic patients.
    Kumar M; Rehan HS; Puri R; Yadav M; Gupta LK
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S64-S67. PubMed ID: 30595323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the rs7395662 SNP in the MADD-FOLH1 and several environmental factors with serum lipid levels in the Mulao and Han populations.
    Huang KK; Yin RX; Zeng XN; Huang P; Lin QZ; Wu J; Guo T; Wang W; Yang DZ; Lin WX
    Int J Med Sci; 2013; 10(11):1537-46. PubMed ID: 24046529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common sequence variants in pharmacodynamic and pharmacokinetic pathway-related genes conferring LDL cholesterol response to statins.
    Chien KL; Wang KC; Chen YC; Chao CL; Hsu HC; Chen MF; Chen WJ
    Pharmacogenomics; 2010 Mar; 11(3):309-17. PubMed ID: 20235787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of 6 genetic variants on the efficacy of statins in patients with dyslipidemia.
    Cano-Corres R; Candás-Estébanez B; Padró-Miquel A; Fanlo-Maresma M; Pintó X; Alía-Ramos P
    J Clin Lab Anal; 2018 Oct; 32(8):e22566. PubMed ID: 29732606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin.
    Mangravite LM; Medina MW; Cui J; Pressman S; Smith JD; Rieder MJ; Guo X; Nickerson DA; Rotter JI; Krauss RM
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1485-92. PubMed ID: 20413733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of MYLIP rs3757354 SNP and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han populations.
    Yan TT; Yin RX; Li Q; Huang P; Zeng XN; Huang KK; Wu DF; Aung LH
    Lipids Health Dis; 2012 Oct; 11():141. PubMed ID: 23107276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Eight Functional Polymorphisms and Haplotypes in the Cholesterol Ester Transfer Protein (CETP) Gene and Dyslipidemia in National Minority Adults in the Far West Region of China.
    Guo S; Hu Y; Ding Y; Liu J; Zhang M; Ma R; Guo H; Wang K; He J; Yan Y; Rui D; Sun F; Mu L; Niu Q; Zhang J; Li S
    Int J Environ Res Public Health; 2015 Dec; 12(12):15979-92. PubMed ID: 26694435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
    J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.